An open randomised clinical study comparing Arimidex (TM) [anastrozole] with Nolvadex (TM) [tamoxifen] as adjuvant therapies in post-menopausal women with breast cancer already being treated with Nolvadex for at least two years

Trial Profile

An open randomised clinical study comparing Arimidex (TM) [anastrozole] with Nolvadex (TM) [tamoxifen] as adjuvant therapies in post-menopausal women with breast cancer already being treated with Nolvadex for at least two years

Completed
Phase of Trial: Phase III

Latest Information Update: 14 Feb 2013

At a glance

  • Drugs Anastrozole (Primary) ; Tamoxifen
  • Indications Early breast cancer
  • Focus Therapeutic Use
  • Acronyms ITA
  • Most Recent Events

    • 12 Nov 2008 Last checked against ClinicalTrials.gov record.
    • 12 Nov 2008 Actual patient number identified as 448 from ClinicalTrials.gov.
    • 12 Nov 2008 Actual trial completion date identified as May 2006 from ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top